DE69607904T2 - Potenzierung von Serotonin-Wirkstoffresponz - Google Patents

Potenzierung von Serotonin-Wirkstoffresponz

Info

Publication number
DE69607904T2
DE69607904T2 DE69607904T DE69607904T DE69607904T2 DE 69607904 T2 DE69607904 T2 DE 69607904T2 DE 69607904 T DE69607904 T DE 69607904T DE 69607904 T DE69607904 T DE 69607904T DE 69607904 T2 DE69607904 T2 DE 69607904T2
Authority
DE
Germany
Prior art keywords
potentiation
serotonin
drug response
serotonin drug
tryptophan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69607904T
Other languages
English (en)
Other versions
DE69607904D1 (de
Inventor
David Taiwai Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE69607904D1 publication Critical patent/DE69607904D1/de
Application granted granted Critical
Publication of DE69607904T2 publication Critical patent/DE69607904T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69607904T 1995-08-16 1996-08-16 Potenzierung von Serotonin-Wirkstoffresponz Expired - Fee Related DE69607904T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US244095P 1995-08-16 1995-08-16

Publications (2)

Publication Number Publication Date
DE69607904D1 DE69607904D1 (de) 2000-05-31
DE69607904T2 true DE69607904T2 (de) 2000-10-05

Family

ID=21700772

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69607904T Expired - Fee Related DE69607904T2 (de) 1995-08-16 1996-08-16 Potenzierung von Serotonin-Wirkstoffresponz

Country Status (9)

Country Link
EP (1) EP0759299B1 (de)
AT (1) ATE192042T1 (de)
AU (1) AU6776196A (de)
DE (1) DE69607904T2 (de)
DK (1) DK0759299T3 (de)
ES (1) ES2145977T3 (de)
GR (1) GR3034007T3 (de)
PT (1) PT759299E (de)
WO (1) WO1997006792A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6231833B1 (en) 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
GB9714675D0 (en) * 1997-07-11 1997-09-17 Smithkline Beecham Plc Novel composition
EP1075264B1 (de) * 1998-05-08 2004-12-01 PHARMACIA & UPJOHN COMPANY Neue arzneimittelkombinationen aus reboxetin und pindolol
WO1999061014A2 (en) * 1998-05-28 1999-12-02 Sepracor Inc. Compositions and methods employing r(-) fluoxetine and other active ingredients
US6046242A (en) * 1998-11-27 2000-04-04 Basf Aktiengesellschaft Use of aryl-substituted cyclobutylalkylamines for treating urinary incontinence
AR021155A1 (es) 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
US6218395B1 (en) * 1999-08-02 2001-04-17 Conrad Melton Swartz Centrally-acting beta-blockers and serotonin-enhancers for the treatment of anxiety disorders and adjustment disorders with anxiety
GB0004003D0 (en) * 2000-02-22 2000-04-12 Knoll Ag Therapeutic agents
US7034059B2 (en) 2001-07-02 2006-04-25 Sepracor Inc. Methods of using norfluoxetine
US6635675B2 (en) * 2001-11-05 2003-10-21 Cypress Bioscience, Inc. Method of treating chronic fatigue syndrome
US6602911B2 (en) 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
US7704527B2 (en) 2002-10-25 2010-04-27 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
EP1556024A4 (de) * 2002-10-25 2007-01-17 Collegium Pharmaceutical Inc Zusammensetzungen von milnacipran mitpulsativer freisetzung
US20040121010A1 (en) * 2002-10-25 2004-06-24 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040228830A1 (en) * 2003-01-28 2004-11-18 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US7994220B2 (en) 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
WO2010132521A1 (en) * 2009-05-13 2010-11-18 Sepracor Inc. Compositions comprising transnorsertraline and serotonin receptor 1a agonists/ antagonists and uses thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155669A (en) * 1962-06-22 1964-11-03 Res Lab Dr C Janssen N V 2, 4, 8-triaza-spiro (4, 5) dec-2-enes
NL300886A (de) * 1962-11-23
US3471515A (en) * 1965-02-01 1969-10-07 Sandoz Ag (2-hydroxy-3-substituted aminopropoxy)indoles
US3466325A (en) * 1965-04-30 1969-09-09 Haessle Ab 1-(ortho-alkenyl phenoxy) - 2-hydroxy-3-isopropylaminopropanes and the salts thereof
DE1668055B2 (de) * 1967-03-10 1973-09-06 Farbwerke Hoechst AG, vormals Mei ster Lucius & Bruning, 6000 Frankfurt Basisch substituierte cyclopentylphenolaether, deren salze mit physiologisch vertraeglichen saeuren und verfahren zu deren herstellung
GB1308191A (en) * 1970-04-06 1973-02-21 Science Union & Cie Thiochroman derivatives and a process for preparing them
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
NL7503310A (nl) * 1975-03-20 1976-09-22 Philips Nv Verbindingen met antidepressieve werking.
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
FR2508035A1 (fr) * 1981-06-23 1982-12-24 Fabre Sa Pierre Derives d'aryl-1-aminomethyl-2 cyclopropanes carboxamides (z), leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
US4853377A (en) * 1985-10-15 1989-08-01 Pollack Robert L Method and composition for increasing production of serotonin
US4956388A (en) * 1986-12-22 1990-09-11 Eli Lilly And Company 3-aryloxy-3-substituted propanamines
US5013761A (en) * 1988-06-03 1991-05-07 Eli Lilly And Company Serotonin antagonists
GB8909209D0 (en) * 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
AU645681B2 (en) * 1991-05-02 1994-01-20 John Wyeth & Brother Limited Piperazine derivatives
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
EP0714663A3 (de) * 1994-11-28 1997-01-15 Lilly Co Eli Potenzierung von Wirkstoffresponz durch Serotonin 1A Rezeptor Antagonisten

Also Published As

Publication number Publication date
GR3034007T3 (en) 2000-11-30
ES2145977T3 (es) 2000-07-16
EP0759299B1 (de) 2000-04-26
WO1997006792A1 (en) 1997-02-27
DE69607904D1 (de) 2000-05-31
AU6776196A (en) 1997-03-12
PT759299E (pt) 2000-09-29
ATE192042T1 (de) 2000-05-15
EP0759299A1 (de) 1997-02-26
DK0759299T3 (da) 2000-08-07

Similar Documents

Publication Publication Date Title
ATE192042T1 (de) Potenzierung von serotonin-wirkstoffresponz
DK0531410T3 (da) (+)-alfa-(2,3-Demethoxyphenyl)-1-(2-(4-fluorphenyl)ethyl)-4-piperidinmethanol
CA2134038A1 (en) Potentiation of Drug Response
EA199900561A1 (ru) Производные сульфонамида, способ их получения и их использование в качестве лекарственных средств
EA200101156A1 (ru) ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ
ES2144077T3 (es) Formas de administracion que contienen sales solidas de acido r-tioctico con liberacion y biodisponibilidad mejoradas.
DK0693282T3 (da) Enteriske duloxetinpellets
CY2004005I1 (el) Σουλφοναμιδη, η παρασκευη και χρηση της ως φαρμακου και ενδιαμεσης ουσιας
EA200100022A1 (ru) Композиции с контролируемым высвобождением пароксетина
DE59608732D1 (de) Lagerstabile arzneiformen
EA200200571A1 (ru) Новая композиция и ее применение
NO963984D0 (no) Nye, 1,4-disubstituerte piperidinderivater anvendbare som legemidler som virker på glutamatreseptorer
FI940192A0 (fi) 2-(4-hydroksipiperidino)-1-alkonolijohdannaisia verettömyyden vastaisina aineina
ES2071663T3 (es) Analogo de fluoxetina.
ATE311865T1 (de) Verwendung von r-enantiomeren nichtsteroidaler entzündungshemmer zur vorbeugung der alzheimerschen krankheit
ES2191942T3 (es) Nueva utilizacion de un antagonista especifico de los receptores 5ht2a.
DK0590150T3 (da) (-)-(S)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decan-L-tartrat
ES2185153T3 (es) Uso de mefloquina(+) para el tratamiento de la malaria.
SE9302218D0 (sv) New use
BR0016941A (pt) Derivados de aminometil-fenil-ciclohexanona
KR920019365A (ko) 디리트로마이신을 함유하는 약학 제형
DK1021442T3 (da) Derivater af 8-azabicyclo[3.2.1] octan-3-methanamin som ligander til D2- og D3-dopaminreceptorerne og 5HT1A- og 5HT2-serotoninreceptorerne
AR023452A1 (es) Utilizacion del osanetant para preparacion de medicamentos utiles en el tratamiento de los trastornos del humor
KR960003718A (ko) 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
NO882724L (no) Smertepreparat.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee